Features of the functioning of innate immunity in children with chronic idiopathic urticaria
https://doi.org/10.20538/1682-0363-2022-3-67-72
Abstract
Aim. To study the features of the functioning of innate immunity in children with chronic idiopathic urticaria.
Materials and methods. The study included 28 children of both sexes aged 6–16 years with chronic idiopathic urticaria (CIU). The median age of the patients was 8 years (p = 0.045). Clinical research methods included an analysis of complaints and anamnestic data, as well as an objective examination of the child (dynamics of urticaria, severity of itching, the presence of angioedema). Immunological techniques included determination of the number of monocytes expressing CD14+CD282+, CD14+CD284+, CD14+CD289+, the number of peripheral blood lymphocytes expressing CD3+CD16+, the levels of immunoglobulin (Ig) E, lactoferrin, interferon (IFN) γ, interleukin (IL)4, and IL-6, and a nitroblue tetrazolium test.
Results. In the course of the study, an increase in the expression of Toll-like receptors TLR2 and TLR4 by monocytes, a decrease in the expression of TLR9 by monocytes, a significant rise in lactoferrin levels, a slight decrease in the number of natural killer (NK) cells, a decrease in microbicidal activity and adaptive reserves, a rise in IgE levels, a decrease in IL-4 levels, and an increase in IFNγ and IL-6 were revealed in children with CIU.
Conclusion. The immunological changes revealed during the study indicate multidirectional expression of Toll-like receptors, disturbances in the work of the cellular components of innate immunity, and a launch of a proinflammatory cytokine cascade in children with CIU, which can serve as a mainstay for the development of new schemes for personalized therapy of CIU in children.
About the Authors
S. V. Maltsev
Rostov State Medical University (RostSMU)
Russian Federation
Competing Interests:
Russian Federation
29, Nakhichevansky Lane, Rostov-on-Don, 344022
Competing Interests:
The authors declare the absence of obvious and potential conflicts of interest related to the publication of this article
L. P. Sizyakina
Rostov State Medical University (RostSMU)
Russian Federation
Competing Interests:
Russian Federation
29, Nakhichevansky Lane, Rostov-on-Don, 344022
Competing Interests:
The authors declare the absence of obvious and potential conflicts of interest related to the publication of this article
A. A. Lebedenko
Rostov State Medical University (RostSMU)
Russian Federation
Competing Interests:
Russian Federation
29, Nakhichevansky Lane, Rostov-on-Don, 344022
Competing Interests:
The authors declare the absence of obvious and potential conflicts of interest related to the publication of this article
References
1. Pite H., Wedi B., Borrego L.M. et al. Management of childhood urticaria: current knowledge and practical recommendations. Acta Derm. Venereol. 2013;93(5):500–508. DOI: 10.2340/00015555-1573.
2. Ulrich W. Anti-IgE for chronic urticaria – are children little adults after all? Pediatr. Allergy Immunol. 2015;26(6):488– 489. DOI: 10.1111/pai.12424.
3. Fricke J., Avila G., Keller T. et al. Prevalence of chronic urticaria in children and adults across the globe: Systematic review with meta-analysis. Allergy. 2020;75(2):423–432. DOI: 10.1111/all.14037.
4. Goncalo M., Gimenez-Arnau A., Al-Ahmad M. et al. The global burden of chronic urticaria for the patient and society. Br. J. Dermatol. 2021;184(2):226–236. DOI: 10.1111/bjd.19561.
5. Sanchez-Borges M., Asero R., Ansotegui I.J. et al. Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ J. 2012;5(11):125–147. DOI: 10.1097/WOX.0b013e3182758d6c.
6. Yilmaz E.A., Karaatmaca B., Cetinkaya P.G. et al. The persistence of chronic spontaneous urticaria in childhood is associated with the urticaria activity score. Allergy Asthma Proc. 2017;38(2):136–142. DOI: 10.2500/aap.2017.38.4029.
7. Greenberger P.A. Chronic urticaria: new management options. World Allergy Organ J. 2014;7(1):31. DOI: 10.1186/19394551-7-31.
8. Zuberbier T., Aberer W., Asero R. et al. The EAACI/GA(2) LEN/ EDF/WAO Guideline for the Definition, Classification, Diagnosis and Management of Urticaria. The 2017 Revision and Update. Allergy. 2018. DOI: 10.1111/all.13397.
9. Федеральные клинические рекомендации по оказанию медицинской помощи детям с крапивницей. М.: Союз педиатров России, 2016:51.
10. Poddighe D., De Amici M., Marseglia G.L. Spontaneous (autoimmune) chronic urticaria in children: current evidences, diagnostic pitfalls and therapeutic management. Recent. Pat. Inflamm. Allergy Drug Discov. 2016;10(1):34–39. DOI: 10.2174/1872213X10666160219163502.
11. Намазова-Баранова Л.С., Вишнёва Е.А., Калугина В.Г., Алексеева А.А., Левина Ю.Г., Добрынина Е.А. и др. Современные возможности терапии хронической крапивницы у детей. Педиатрическая фармакология. 2018;15(3):233– 237. DOI: 10.15690/pf.v15i3.1903.
12. Мальцев С.В., Сизякина Л.П., Лебеденко А.А. и др. Нарушения цитокинового статуса у детей с крапивницей. Медицинский вестник Юга России. 2020;11(4):51–57. DOI: 10.21886/2219-8075-2020-11-4-51-57.
13. Maurer M., Rosen K., Hsieh H.J. et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N. Engl. J. Med. 2013;368(10):924–935. DOI: 10.1056/NEJMoa1215372.
14. Casale T.B., Bernstein J.A., Maurer M. et al. Similar efficacy with Omalizumab in chronic idiopathic/spontaneous urticaria despite different background therapy. J. Allergy Clin. Immunol. Pract. 2015;3(5):743–750. DOI: 10.1016/j.jaip.2015.04.015.
15. Kasperska-Zajac A., Damasiewicz-Bodzek A., Tyrpień-Golder K. et al. Circulating soluble receptor for advanced glycation end products is decreased and inversely associated with acute phase response in chronic spontaneous urticaria. Innate immunity. Inflamm. Res. 2016;65(5):343–346. DOI: 10.1007/S00011-016-0914-5.
16. Сорокина Е.В., Сивакова Н.Г., Ахматова Н.К. и др. Эффекторы врожденного иммунитета при хронической спонтанной крапивнице. Клиническая дерматология и венерология. 2020;19(3):337–342. DOI: 10.17116/KLINDERMA202019031337.
17. Futata E., Azor M., Dos Santos J.C. et al. Impaired IFN-α secretion by plasmacytoid dendritic cells induced by TLR9 activation in chronic idiopathic urticaria. British Journal of Dermatology. 2011;164(6):1271–1279. DOI: 10.1111/j.13652133.2010.10198.x.
18. Бойко О.В., Ахминеева А.Х., Гудинская Н.И. и др. Биохимические и иммунологические маркеры в диагностике патологических состояний. Фундаментальные исследования. 2013;9(3):327–329.
19. Кузнецов И.А., Потиевская В.И., Качанов И.В. и др. Роль лактоферрина в биологических средах человека. Современные проблемы науки и образования. 2017;3. URL: http://www.science-education.ru/ru/article/view?id=26522
20. Абакушина Е.В., Кузьмина Е.Г., Коваленок Е.И. Основные свойства и функции NK-клеток человека. Иммунология. 2012;4:220–224.
21. Данилычева Е.В. Крапивница: есть ли проблемы? Аллергология и иммунология. 2012;2:42–47.
22. Моисеева Е.Г., Пасечник А.В., Михеева М.С., Дроздо ва Г.А. Характеристика фагоцитоза и апоптоз нейтрофилов при аллергическом воспалении. Успехи современного естествознания. 2005;7:38–39.
23. Kessel A., Helou W., Bamberger E. et al. Elevated serum total IgE-apotential marker for severe chronic urticaria. International Archives of Allergy and Immunology. 2010;153(3):288– 293. DOI: 10.1159/000314370.
24. Chang K.L., Yang Y.H., Yu H.H. et al. Analysis of serum total IgE, specific IgE and eosinophils in children with acute and chronic urticaria. Journal of Microbiology, Immunology and Infection. 2013;46(1):53–58. DOI: 10.1016/j.jmii.2011.12.030.
25. Симбирцев А.С. Цитокины в иммунопатогенезе аллергии. РМЖ. 2021;1:32–37. DOI: 10.32364/2587-6821-2021-5-132-37.
26. Kasperska-Zajac A. Acute-phase response in chronic urticaria. Journal of the European Academy of Dermatology and Venereology. 2011;10:370–376. DOI: 10.1111/j.14683083.2011.04366.x.
27. Krause K. Complete remission in 3 of 3 anti-IL-6-treated patients with Schnitzler syndrome. Journal of Allergy and Clinical Immunology. 2012;129(3):848–850. DOI: 10.1016/j.jaci.2011.10.031.
28. Makol A., Gibson L.E., Michet C.J. Successful use of interleukin 6 antagonist tocilizumab in a patient with refractory cutaneous lupus and urticarial vasculitis. J. Clin. Rheumatol. 2012;18(2):92–95. DOI: 10.1097/RHU.0b013e31823ecd73.
29. Deza G. Emergi–ng biomarkers and therapeutic pipelines for chronic spontaneous urticaria. The Journal of Allergy and Clinical Immunology: In Practice. 2018;6(4):1108–1117. DOI: 10.1016/j.jaip.2018.02.024.
30. Dos Santos J.C., de Brito C.A., Futata E.A. Up-regulation of chemokine C–C ligand 2 (CCL2) and C-X-C chemokine 8 (CXCL8) expression by monocytes in chronic idiopathic urticaria. Clinical & Experimental Immunology. 2012;167(1):129– 137. DOI: 10.1111/j.1365-2249.2011.04485.x.
Review
For citations:
Maltsev S.V., Sizyakina L.P., Lebedenko A.A. Features of the functioning of innate immunity in children with chronic idiopathic urticaria. Bulletin of Siberian Medicine. 2022;21(3):67-72. https://doi.org/10.20538/1682-0363-2022-3-67-72
Views:
399
Email this article 